Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Tenax Therapeutics, Inc.
The company reported another event it considers important. An 8-K is the notice a US public company must file within four business days of a major event.
tenaxthera.comAI Executive Summary
AI-powered analysis of 8-K filing content
Tenax Therapeutics announced an enrichment strategy for its LEVEL-2 clinical trial of TNX-103 based on Phase 3 LEVEL trial insights, temporarily pausing recruitment to implement new enrollment criteria focused on pulmonary hypertension and heart failure patients, while requesting a Type C meeting with the FDA to discuss levosimendan development.
Key Takeaways
LEVEL-2 trial recruitment has been temporarily paused to implement amended enrollment criteria targeting specific patient populations (PH-HFpEF)
The enrichment strategy is based on learnings from the completed Phase 3 LEVEL trial, indicating data-driven optimization of clinical development
1 more takeaway
Related Filings (1)
1 more filing from Tenax Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Tenax Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.